Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients

Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients

BackgroundMetastatic breast cancer (mBC) is a heterogeneous disease with varying responses to treatments and clinical outcomes, still requiring the identification of reliable predictive biomarkers. In this context, liquid biopsy has emerged as a powerful tool to assess in real-time the evolving land...

Full description

Bibliographic Details
Main Authors: Elena Muraro, Fabio Del Ben, Matteo Turetta, Daniela Cesselli, Michela Bulfoni, Rita Zamarchi, Elisabetta Rossi, Simon Spazzapan, Riccardo Dolcetti, Agostino Steffan, Giulia Brisotto
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
metastatic breast cancer (mbc)
liquid biopsy
circulating tumor cells (CTCs)
anti-tumor T-cells
T-cell receptor (TCR)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.983887/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.983887/full

Similar Items